Modulation of C-reactive protein expression

Details for Australian Patent Application No. 2004256404 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Graham, Mark J.; Crooke, Rosanne M.

Agent Davies Collison Cave

Pub. Number AU-B-2004256404

PCT Pub. Number WO2005/005599

Priority 60/540,042 28.01.04 US; 60/475,272 02.06.03 US; 10/858,500 01.06.04 US

Filing date 2 June 2004

Wipo publication date 20 January 2005

Acceptance publication date 29 October 2009

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/00 (2006.01) Mutation or genetic engineering

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/005599 Priority application(s): WO2005/005599

29 October 2009 Application Accepted

  Published as AU-B-2004256404

25 February 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004256410-Connector

2004256397